Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Amgen Inc.."
12 result(s) displayed (1 - 12 of 12)
The Israeli drug giant's CEO tells attendees at the JPMorgan Healthcare Conference that the company is surveying all nonlabor expenditures to find efficiencies that would yield cash it would use on fewer therapeutic areas. Continue reading
Posted on January 10, 2013 2:21 PM
David Brennan steps down as the drugmaker faces one of the steepest patent cliffs in the sector. Continue reading
Posted on April 26, 2012 3:22 PM
Amgen Inc. has agreed to buy nearly all of Mustafa Nevzat Ilac Sanayii AS to raise its profile in Turkey Continue reading
Posted on April 25, 2012 10:27 AM
The deal for the fibrosis drugmaker could top $562 million Continue reading
Posted on February 14, 2012 3:22 PM
The draft outlines the approval process for biosimilars Continue reading
Posted on February 13, 2012 9:16 AM
New hires at both Kirkland and Dewey & LeBouef pay off, and Apache remains faithful to Goldman. Continue reading
Posted on February 3, 2012 12:00 PM
The pharma strikes a solid deal for what could be a revolutionary cancer drug. Continue reading
Posted on January 20, 2012 12:00 PM
CEO Paul Bisaro says the pharma will seek balance through M&A Continue reading
Posted on January 12, 2012 12:42 PM
In 2011, risk sharing returned to dealmaking in the sector as overconfidence left the market. Continue reading
Posted on December 9, 2011 12:00 PM
For every Genentech or Amgen, there's a host of research-based companies that have struggled to get by. Here's the story of how three biotechs kept themselves going when times got tough. Continue reading
Posted on April 25, 2011 12:45 PM
The San Fernando city was once home to Countrywide and other subprime purveyors. But while the recession hit hard, there's a diversity of tech and middle-market companies to soften the blow. And a few Hollywood types, too. Continue reading
Posted on September 18, 2009 2:00 PM
Biotech powerhouse University of California, San Francisco, explores the frontiers of academic and corporate friendship. Continue reading
Posted on September 4, 2009 12:40 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
